The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
The owner of Nine West shoes and Juicy Couture makeup has signed a deal with Canadian marijuana company Tilray looking at developing cannabis-infused foot creams, cosmetics and other consumer products.
Tilray agreed to pay Authentic Brands Group $100 million and up to $250 million in cash and stock, depending on the success of the venture, to create and distribute consumer cannabis products as the retailer's preferred supplier, the companies announced Tuesday.
The deal also gives Tilray access to a wide consumer base and massive global distribution network.
"They own over 50 iconic brands they have the products in over 100,000 points of sale, over 4,500 free standing and shop and shops around the world," Tilray CEO Brendan Kennedy said Tuesday in an interview on CNBC's "Squawk Box." "If you can imagine a Nine West foot cream where we put samples in over a million pairs of shoes that are sold by them every year, it introduces new consumers to cannabis based products, CBD primarily."
Tilray's shares fell by more than 12 percent in intraday trading Tuesday.
The two companies will immediately focus on launching cannabis products in Canada and CBD in the U.S. The deal gives Tilray a guaranteed minimum payment of up to $10 million annually for a decade and the right to receive up to 49 percent of the net revenue generated from the new cannabis products.
The deal illustrates how quickly CBD, short for cannabidiol, is going mainstream. President Donald Trump signed the farm bill last month that legalized hemp-based CBD, a move widely thought to fuel an already growing industry. CBD is a non-psychoactive compound found in the cannabis plant that has become popular among consumers for its perceived health benefits.
Kennedy said the passage of the farm bill has prompted them to "move quickly to get products into the market."
Some possibilities include cannabis-based foot cream at Nine West, a CBD cream for tennis elbow or Juicy Couture creating a line of beauty and cosmetics products infused with CBD, Kennedy said.
"We see extraordinary potential for cannabis in the fast-growing health and wellness category – particularly for CBD products in the United States and around the world – and are excited about this long-term partnership," Authentic Brands Executive Vice Chairman Daniel Dienst said in a statement.
CORRECTION: This article was updated to correct the terms of the deal. Tilray is paying
Authentic Brands $100 million.